A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.
Irish Examiner on MSN5h
Weight-loss jabs ‘slash alcohol cravings and curb heavy drinking’Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing for alcoholic drinks ...
Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.
A recent review and meta-analysis of semaglutide studies found that this drug can significantly reduce the risk of ...
Hosted on MSN2hOpinion
On the Death of a Loved OneThere is a loss of words with the sudden death of a loved one. To say too little is offensive and somehow diminishes your ...
Taking tiny doses of GLP-1 medication has been touted for weight management, perimenopause symptoms, even longevity. But is ...
Doctors say Pope Francis receiving occasional supplemental oxygen, responding to strengthened drug therapy for pneumonia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback